Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Cash Flows (Unaudited)

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended				9 Months Ended		12 Months Ended
	Mar. 31, 2026	Sep. 30, 2025	Mar. 31, 2025	Sep. 30, 2024	Mar. 31, 2026	Mar. 31, 2025	Jun. 30, 2025
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (6,360,336)	$ (4,837,738)	$ (54,067,346)	$ (354,310)	$ (14,289,468)	$ (54,851,839)
Adjustments to Reconcile Net Loss to Net Cash Used in Operating Activities:
Issuance of common stock for services					741,248	51,348,000
Common stock issuable for services					3,570,000
Amortization of prepaid stock based expenses					7,270,003	1,505,115
Foreign currency transaction loss					19,190	88,184
Depreciation expense	316		0		670
Amortization of debt discounts					198,362	193,283
Amortization of right-of-use assets					15,650	14,952
Change in fair value of derivative liabilities	18,146		(47,119)		(49,876)	(113,487)
Change in fair value of warrant liability	(182,517)				(776,227)
Derivative expense			59,271			95,012
Loss (gain) on extinguishment of debt, net	74,235		809,954		(135,943)	840,032
Non-cash interest expense					5,843	5,519
Accretion of put premium					37,450
Changes in Assets and Liabilities:
GST receivable					(5,504)	(880)
Prepaid expenses					(68,669)	1,312
Other current assets					(33,659)
Accounts payable					(335,235)	118,706
Employee benefit liability					38,573	27,917
Accrued expenses and other payables					(308,783)	342,223
Accrued interest					34,365	89,179
Operating lease liability					(8,643)	(16,210)
NET CASH USED IN OPERATING ACTIVITIES					(4,080,653)	(312,982)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of equipment					(4,912)
NET CASH USED IN INVESTING ACTIVITIES					(4,912)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from convertible promissory notes, net of original issue discounts and issue costs					100,000	150,000
Proceeds from issuance of convertible Series C Preferred stock, net of issuance cost					950,099
Proceeds from exercise of Series C warrants					1,000,000
Repayment of convertible notes					(203,350)	(8,000)
Repayment of notes					(671,777)	(98,400)
Repayment of loans payable - related party					(169,194)
Proceeds from the sale of common stock, net of offering costs					3,314,458
Proceeds from note payable					75,000	145,000
Proceeds from loans payable - related parties					78,249	294,400
Deferred offering costs						(65,000)
NET CASH PROVIDED BY FINANCING ACTIVITIES					4,473,485	418,000
Effect of exchange rate changes on cash					43,694	(75,343)
NET INCREASE IN CASH					431,614	29,675
CASH AT BEGINNING OF PERIOD		$ 12,088		$ 21,085	12,088	21,085	$ 21,085
CASH AT END OF PERIOD	$ 443,702		$ 50,760		443,702	50,760	$ 12,088
Cash paid during the period:
Interest					126,855	21,625
Income Tax
Supplemental Disclosure of Non-Cash Investing and Financing Activities
Reduction of put premium related to conversions of convertible notes					114,399	10,229
Conversion of convertible notes and accrued interest to common stock					416,291	79,686
Settlement of accounts payable for shares of common stock						129,354
Settlement of loans to former director for shares of common stock						74,395
Settlement of loans payable including accrued interest for shares of common stock					125,765	86,248
Defferred offering cost charged to additional paid in capital upon closing of offering					291,773
Issuance of common stock related to debt exchange agreement					125,764
Debt discounts related to derivative liability						150,000
Issuance of common stock and common stock issuable for prepaid services (net of amortized portion)					1,026,729	22,375,995
Deemed dividend related to Series C Preferred Stock					932,246
Reclassification of warrant liability into equity upon exercise of Series C warrants					$ 1,805